Daiichi Sankyo Company Limited ( ) is a joint holding company established in 2005 by Sankyo Co., Ltd. and Daiichi Pharmaceutical Co., Ltd., which are pharmaceutical companies based in Japan. Its main offices are located in Chūō-ku, Tokyo.
Jul 16 - Ranbaxy Laboratories Ltd's deal for a takeover by Japan's Daiichi Sankyo remains on track and the Indian firm will give U.S. authorities all information needed for a probe within the next ...
1m 7s |
a month ago
Reuters
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Sharmila Joshi of Prabhudas Lilladher is of the view that Ranbaxy is looking good at current level. On the operation front Daiichi Sankyo should be able to leverage Ranbaxy acquisition and increase ...
2 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Rhenu Bhuller, pharmaceutical analyst at Frost & Sullivan, talks with Bloomberg's Bernard Lo from Singapore about Daiichi Sankyo Co.'s purchase of Ranbaxy Laboratories Ltd., the role of generic ...
2 months ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Malvinder Singh, MD and CEO, Ranbaxy Laboratories, said Daiichi Sankyo would get 50.1% stake in Ranbaxy. "Ranbaxy will turn into a debt free company post deal. About USD 440 million FCCBs will be ...
2 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Masaya Tamae of Daiichi Sankyo said Ranbaxy's product pipeline and geographical presence is attractive. Tamae told CNBC-TV18 that they will explore other options if the 20% open offer does not happen....
2 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Positive comments on Ranbaxy- Daiichi Sankyo deal are seen coming from the market experts. The deal is seen as the first generics-proprietary partnership in global pharma. Udayan Mukherjee, CNBC-TV18 ...
2 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to: